Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02887235 · ClinicalTrials.gov registry record · NA

Food as Medicine: An RCT to Study the Effect of Home Delivered, Medically Tailored Meals on Patients With Metastatic Cancer

A NA study of Quality of Life, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
6
Enrollment target
1
Study location

NCT02887235 is a NA study of Quality of Life that has completed, run by NYU Langone Health. The registered enrollment target is 6 participants, below the 453-participant average among 107 other Quality of Life trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02887235, a NA study of Quality of Life, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether medically tailored meals (HDTM) can improve quality of life for patients with metastatic cancer.

Conditions Studied

Interventions

  • OTHER Home Delivered, Medically Tailored Meals (HDTM)

Study Locations (1)

New York

  • NYU Perlmutter Cancer Center - New York

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2016-03
Est. Completion 2019-08-08
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT02887235

The ClinicalTrials.gov registry entry for NCT02887235 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 453-participant average among 107 other Quality of Life trials with a reported enrollment target (99% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Quality of Life appearing as the primary indexed condition, and to 1 intervention - of which Home Delivered, Medically Tailored Meals (HDTM) is the first listed.

NCT02887235 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02887235 about?

NCT02887235 is a clinical study titled "Food as Medicine: An RCT to Study the Effect of Home Delivered, Medically Tailored Meals on Patients With Metastatic Cancer". The purpose of this study is to determine whether medically tailored meals (HDTM) can improve quality of life for patients with metastatic cancer.

What is the current status of trial NCT02887235?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2016-03. Estimated completion is 2019-08-08.

What conditions does trial NCT02887235 study?

This clinical trial studies the following conditions: Quality of Life.

What interventions are being tested in trial NCT02887235?

The interventions under investigation include: Home Delivered, Medically Tailored Meals (HDTM) (OTHER).

Who is sponsoring clinical trial NCT02887235?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02887235 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Quality of Life

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.